CYNTHIA BENSON: Open Payments
NPI 1477027506 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,132 in 58 payments from 14 companies in 2025. Trend: 2023 $491 · 2024 $476 · 2025 $1,132
Food & beverage: $1,132
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $183 |
| Axsome Therapeutics, Inc. | 11 | $176 |
| Vanda Pharmaceuticals Inc. | 6 | $175 |
| Teva Pharmaceuticals USA, Inc. | 10 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| Lundbeck LLC | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Alkermes, Inc. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Boston Scientific Corporation | 2 | $44 |
Products named: INGREZZA, FANAPT, REXULTI, Sunosi, AUSTEDO XR, CAPLYTA, Auvelity, LYBALVI.
Industry payments across UT — which companies pay providers there.
